Tag: Aequus Pharmaceuticals
July 16, 2018
Aequus Extends and Enhances Commercial Agreement to Promote Vistitan in Canada
Aequus Pharmaceuticals (TSXV:AQS) has announced it has agreed to new terms for its promotional service agreement with Sandoz on Vistitan... March 5, 2018
Aequus and Ehave Announce Collaboration Agreement for Patient Data
Aequus Pharmaceuticals and Ehave announced a new collaboration agreement with each other on the basis of Aequus using Ehave's bioinformatics... January 31, 2018
Aequus and Camargo Prepare for Meeting with FDA to Advance Anti-Nausea Patch
Aequus Pharmaceuticals (TSXV: AQS) a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, today announced plans to... January 25, 2018
Aequus Announces Change to Proposed $300,000 Equity Financing
Aequus Pharmaceuticals (TSXV:AQS) a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, is pleased to... November 16, 2017
Aequus To Receive European Patent for AQS1301
Aequus Pharmaceuticals announced the European Patent Office issued "an intention" to give the company a patent for AQS1301, Aequus' once-weekly... October 10, 2017
Aequus Granted Chinese Patent for Once-Weekly Transdermal Aripiprazole
Aequus Pharmaceuticals (TSXV:AQS; OTCQB:AQSZF) has announced that the State Intellectual Property Office of the People’s Republic of China (SIPO) has... August 30, 2017